全民健保腹膜透析比血液透析省錢嗎？

Is Peritoneal Dialysis Cheaper than Hemodialysis under National Health Insurance?

10.6288/TJPH2007-26-05-05

常逸平(Yi-Ping Chang)；錢慶文(Ching-Wen Chien)；楊耿如(Keng-Ju Yang)

血液透析 ； 腹膜透析 ； 透析費用 ； 察爾森合併症嚴重度指標 ； Hemodialysis ； Peritoneal dialysis ； Dialysis cost ； Charlson Comobidity Index

台灣公共衛生雜誌

26卷5期（2007 / 10 / 01）

400 - 408

繁體中文

Objectives: To compare utilization of National Health Insurance (NHI) resources in terms of health expenses, including dialysis- and non-dialysis-related expenses, between hemodialysis (HD) and peritoneal dialysis (PD) patients. This study also analyzed the influence of different variables, such as gender, age, and disease severity, to two modalities of dialysis. Methods: This study was a retrospective study of new dialyzed patients and their health expenses between 2003 and 2005. Data were abstracted and analyzed from the inpatient/outpatient claim databases of the NHI for 30 consecutive months. Results: Two thousand four hundred seven patients were included in this study; 1,069 (44.4%) were males and 1,338 (55.6%) were females. Two thousand one hundred eighty-nine patients (90.94%) were classified as the ”HD” group and two hundred eighteen patients (9.06%) were classified as the ”PD” group. Most patients belonged to the 45-64 age group (46.28% of the total sample). The average Charlson Index was 5.06. The average individual outpatient dialysis expense in the PD group was NT$459,843/year and NT$618,306/year for the HD group. The average individual outpatient non-dialysis expense in the PD group was NT$47,388/year and NT$45,761/year for the HD group. The average individual inpatient dialysis expense in the PD group was NT$9,504/year and NT$18,981/year for the HD group. The average individual inpatient non-dialysis expense in the PD group was NT$ 37,531/year and NT$40,712/year for the HD group. Conclusions: The individual outpatient and inpatient dialysisrelated expenses of the PD group were significantly less expensive than the HD group (p＜0.001). However, PD patients were younger and had milder disease severity than the HD patients. There were no significant differences in outpatient and inpatient No-ndialysis-related expenses between the PD and HD groups.

Objectives: To compare utilization of National Health Insurance (NHI) resources in terms of health expenses, including dialysis- and non-dialysis-related expenses, between hemodialysis (HD) and peritoneal dialysis (PD) patients. This study also analyzed the influence of different variables, such as gender, age, and disease severity, to two modalities of dialysis. Methods: This study was a retrospective study of new dialyzed patients and their health expenses between 2003 and 2005. Data were abstracted and analyzed from the inpatient/outpatient claim databases of the NHI for 30 consecutive months. Results: Two thousand four hundred seven patients were included in this study; 1,069 (44.4%) were males and 1,338 (55.6%) were females. Two thousand one hundred eighty-nine patients (90.94%) were classified as the ”HD” group and two hundred eighteen patients (9.06%) were classified as the ”PD” group. Most patients belonged to the 45-64 age group (46.28% of the total sample). The average Charlson Index was 5.06. The average individual outpatient dialysis expense in the PD group was NT$459,843/year and NT$618,306/year for the HD group. The average individual outpatient non-dialysis expense in the PD group was NT$47,388/year and NT$45,761/year for the HD group. The average individual inpatient dialysis expense in the PD group was NT$9,504/year and NT$18,981/year for the HD group. The average individual inpatient non-dialysis expense in the PD group was NT$ 37,531/year and NT$40,712/year for the HD group. Conclusions: The individual outpatient and inpatient dialysisrelated expenses of the PD group were significantly less expensive than the HD group (p＜0.001). However, PD patients were younger and had milder disease severity than the HD patients. There were no significant differences in outpatient and inpatient No-ndialysis-related expenses between the PD and HD groups.

1. Alloatti S,Manes M,Paternoster G,Gaiter AM,Molino A,Rosati C.(2000).Peritonal dialysis compared with hemodialysis in the treatment of end-stage renal disease.J Nephrol,13,331-342.
2. Bruns FJ,Seddon P,Saul M,Zeidel ML.(1998).The cost of caring for end-stage kidney disease patients: an analysis based on hospital financial transaction records.J Am Soc Nephrol,9,884-890.
3. Collins AJ,Kasiske B,Herzog C(2007).USRDS(The United States Renal Data System) 2006 ADR: international comparisons.Am J Kidney Dis,49,223-234.
4. Hooi LS,Lim TO,Goh A(2005).Economic evaluation of centre haemodialysis and continuous ambulatory peritoneal dialysis in Ministry of Health hospitals, Malaysia.Nephrol,10,25-32.
5. Kalo Z,Jaray J,Nagy J.(2001).Economic evaluation of kidney transplantation versus hemodialysis in patients with end-stage renal disease in Hungary.Prog Transplant,11,188-193.
6. Lee H,Manns B,Taub K(2002).Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access.Am J Kidney Dis,40,611-622.
7. McMurray SD,Miller J.(1997).Impact of capitalization on free-standing dialysis facilities: can you survive?.Am J Kidney Dis,30,542-548.
8. Miskulin DC,Meyer KB,Athienites NV(2002).Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE study.Am J Kidney Dis,39,324-336.
9. Panagoutsos S,Kantartzi K,Passadakis P(2006).Timely transfer of peritoneal dialysis patients to hemodialysis improves survival rates.Clin Nephrol,65,43-47.
10. Peeters P,Rublee D,Just PM,Joseph A.(2000).Analysis and interpretation of cost data in dialysis: review of western European literature.Health policy,54,209-227.
11. Shih YC,Guo A,Just PM,Mujais S(2005).Impact of initial dialysis modality and modality switches on medicare expenditures of end-stage renal disease patients.Kidney Int,68,319-329.
12. Song YS,Jung H,Shim J,Oh C,Shin GT,Kim H.(2007).Survival analysis of Korean end-stage renal disease patients according to renal replacement therapy in a single center.J Korean Med Sci,22,81-88.
13. Winkelmayer WC,Weinstein MC,Mittleman MA,Glynn RJ,Pliskin JS.(2002).Health economic evaluations: the special case of end-stage renal disease treatment.Med Decis Making,22,417-430.
14. 台灣腎臟醫學會2004透析年度報告
15. 李希敏(2004)。人工腎(透析)服務裝置之市場現況與趨勢。台北:經濟部。
16. 張碧玉(2000)。碩士論文(碩士論文)。台南，國立成功大學高階管理碩士在職專班。
17. 黃尚志、楊五常、陳秀熙(2000)。台灣地區八十八至八十九年度透析評估工作報告。台腎醫誌，14，139-224。
18. 鄭振廷(2003)。碩士論文(碩士論文)。台北，國立陽明大學醫務管理研究所。
19. 謝桂貞(2005)。碩士論文(碩士論文)。台北，國立台灣大學公共衛生學院衛生政策與管理研究所。